VistaGen Therapeutics
VTGN
22 hedge funds and large institutions have $1.02M invested in VistaGen Therapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
0.04% less ownership
Funds ownership: 0.19% → 0.15% (-0.04%)
12% less funds holding
Funds holding: 25 → 22 (-3)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
42% less capital invested
Capital invested by funds: $1.76M → $1.02M (-$740K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$9.16K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$6.13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.22K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.74K |
| 5 |
BlackRock
New York
|
+$1.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$91.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$51K |
| 3 |
William Blair & Company
Chicago,
Illinois
|
-$35K |
| 4 |
RC
RBF Capital
San Francisco,
California
|
-$19K |
VTGN Hedge Fund Activity: Q1 2020 in Review
22 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q1 2020, worth a combined $1.02M — down 42% from $1.76M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VTGN and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 7 added.
The largest buyer was LPL Financial, adding an estimated $9.16K. The largest seller was Wells Fargo, cutting an estimated $91.4K.
- 22 institutional investors held VistaGen Therapeutics (VTGN) as of Q1 2020, down from 25 in Q4 2019.
- Funds reported $1.02M of VistaGen Therapeutics stock for Q1 2020, down 42% quarter-over-quarter.
- 2 funds opened new VistaGen Therapeutics positions in Q1 2020 and 3 closed out, a net change of -1 holder.
- The largest VistaGen Therapeutics buyer in Q1 2020 was LPL Financial, an estimated $9.16K added.
- The largest VistaGen Therapeutics seller in Q1 2020 was Wells Fargo, an estimated $91.4K sold.
Based on aggregated 13F filings for Q1 2020.